Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NASA: Neoadjuvant PD-1-based Treatment in Stage IIIB-IV Melanoma
NCT07740941Phase 2Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Aug 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, ipilimumab, nivolumab in melanoma, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Aug 2026; status: recruiting.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07740941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07740941.